SPARC reports net loss of Rs 41.02 crore in Q3

04 Feb 2016 Evaluate

Sun Pharma Advanced Research Company (SPARC) has reported results for third quarter ended December 31, 2015. 

The company has reported a net loss of Rs 41.02 crore for the quarter ended December 31, 2015 as compared to net loss of Rs 18.91 crore for the same quarter in the previous year. However, the company’s total income has increased by 5.87% to Rs 34.10 crore for the quarter under review from Rs 32.21 crore for the corresponding quarter of the previous year.  

Sun Pharma Advanced Research Company is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

129.00 1.25 (0.98%)
21-Jan-2026 12:11 View Price Chart
Peers
Company Name CMP
Syngene Internation. 599.65
Indegene 481.95
CMS Info Systems 325.50
Sagility 51.96
Smartworks Coworking 444.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×